$15.85
-0.29-1.8%
Last update: Nov 10, 1:34 PM
Nurix Therapeutics Inc
NRIXNASDAQ
The average analyst price target for Nurix Therapeutics is $32.35, 104.1% above the current price. Of 18 analysts, 17 rate it Buy and 1 Hold. Targets range from $16 to $45. The latest change came on Nov 4, 2026, when Wells Fargo lowered its price target on Nurix Therapeutics from $25 to $20 and kept an Equal-Weight rating.
Price Target Range — 11 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
